Comparative efficacy, tolerability, and survival outcomes of various radiopharmaceuticals in castration-resistant prostate cancer with bone metastasis: a meta-analysis of randomized controlled trials

BACKGROUND: A meta-analysis was conducted to assess the impact of radiopharmaceuticals (RPs) in castration-resistant prostate cancer (CRPC) on pain control, symptomatic skeletal events (SSEs), toxicity profile, quality of life (QoL), and overall survival (OS). MATERIALS AND METHODS: The PubMed/MEDLI...

Descripción completa

Detalles Bibliográficos
Autores principales: Tunio, Mutahir, Al Asiri, Mushabbab, Al Hadab, Abdulrehman, Bayoumi, Yasser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590341/
https://www.ncbi.nlm.nih.gov/pubmed/26451085
http://dx.doi.org/10.2147/DDDT.S87304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590341/
https://www.ncbi.nlm.nih.gov/pubmed/26451085
http://dx.doi.org/10.2147/DDDT.S87304

Ejemplares similares